CHICAGO (Reuters) - A new type of personalized cancer therapy in which immune cells are harvested from patients' tumors, grown in the lab and infused back into patients showed dramatic results in a small, government-led trial in women with advanced cervical cancer, U.S. researchers said on Monday. [Category: healthNews] http://feeds.reuters.com/~r/reuters/healthNews/~3/7GnRp0M7l3Q/story01.htm
Read More
No comments:
Post a Comment